Literature DB >> 16879243

Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

M P Hübner1, B J Manfras, M C Margos, D Eiffler, W H Hoffmann, H Schulz-Key, P Kern, P T Soboslay.   

Abstract

Infection with the cestode Echinococcus multilocularis causes human alveolar echinococcosis (AE), a life-threatening disease affecting primarily the liver. Despite the severity of AE, clinical symptoms often develop only many years after infection, which suggests that E. multilocularis has developed mechanisms which depress anti-parasite immune response, thus favouring immune evasion. In this study we examined the production of cytokines, chemokines and the expression of CD molecules on peripheral blood mononuclear cells (PBMC) from AE patients and healthy controls in response to E. multilocularis metacestode culture supernatant, viable E. multilocularis vesicles and E. multilocularis vesicle fluid antigen in vitro. After 48 h of co-culture, E. multilocularis metacestode culture supernatant and E. multilocularis vesicles depressed the release of the proinflammatory cytokine interleukin (IL)-12 by PBMC. This effect was dose-dependent and a suppression of tumour necrosis factor (TNF)-alpha and IL-12 was observed even when PBMC were activated with lipopolysaccharide (LPS). Comparing proinflammatory cytokine release by AE patients and controls showed that the release of IL-12 and TNF-alpha was reduced in AE patients, which was accompanied by an increased number of CD4+ CD25+ cells and a reduced release of the Th2 type chemokine CCL17 (thymus and activation regulated chemokine, TARC), suggesting an anti-inflammatory response to E. multilocularis metacestode in AE patients. Instead the production of interferon (IFN)-gamma and the expression of CD28 on CD4+ T cells were increased in PBMC from AE patients when compared to controls. This was accompanied by a higher release of the Th2-type chemokine CCL22 (macrophage derived chemokine, MDC) supporting that E. multilocularis also generates proinflammatory immune responses. These results indicate that E. multilocularis antigens modulated both regulatory and inflammatory Th1 and Th2 cytokines and chemokines. Such a mixed profile might be required for limiting parasite growth but also for reducing periparasitic tissue and organ damage in the host.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879243      PMCID: PMC1809686          DOI: 10.1111/j.1365-2249.2006.03142.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Serum sIL-2R, TNF-alpha and IFN-gamma in alveolar echinococcosis.

Authors:  Da-Zhong Shi; Fu-Rong Li; B Bartholomot; D A Vuitton; P S Craig
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

Review 2.  Chemokines and the tissue-specific migration of lymphocytes.

Authors:  Eric J Kunkel; Eugene C Butcher
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

3.  Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial.

Authors:  Robert W Summers; David E Elliott; Joseph F Urban; Robin A Thompson; Joel V Weinstock
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

4.  T lymphocyte cytokine profile at a single cell level in alveolar Echinococcosis.

Authors:  J Kilwinski; L Jenne; A Jellen-Ritter; P Radloff; W Flick; P Kern
Journal:  Cytokine       Date:  1999-05       Impact factor: 3.861

5.  Isolation and characterization of a secretory component of Echinococcus multilocularis metacestodes potentially involved in modulating the host-parasite interface.

Authors:  Mirjam Walker; Adriana Baz; Sylvia Dematteis; Marianne Stettler; Bruno Gottstein; Johann Schaller; Andrew Hemphill
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Infection of BALB/c mice with Angiostrongylus costaricensis decreases pulmonary inflammatory response to ovalbumin.

Authors:  L A Pinto; P M C Pitrez; G R Fontoura; D C Machado; M H Jones; C Graeff-Teixeira; R T Stein
Journal:  Parasite Immunol       Date:  2004-03       Impact factor: 2.280

Review 7.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

8.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis.

Authors:  S Bresson-Hadni; J J Laplante; D Lenys; P Rohmer; B Gottstein; P Jacquier; P Mercet; J P Meyer; J P Miguet; D A Vuitton
Journal:  Am J Trop Med Hyg       Date:  1994-12       Impact factor: 2.345

10.  Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization.

Authors:  Diane Sewell; Zhu Qing; Emily Reinke; David Elliot; Joel Weinstock; Matyas Sandor; Zsuzsa Fabry
Journal:  Int Immunol       Date:  2003-01       Impact factor: 4.823

View more
  22 in total

1.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

Review 2.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

3.  Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Viliam Snábel; Peter Fedorocko
Journal:  Parasitol Res       Date:  2008-06-29       Impact factor: 2.289

4.  Echinococcus multilocularis metacestode metabolites contain a cysteine protease that digests eotaxin, a CC pro-inflammatory chemokine.

Authors:  N Mejri; B Gottstein
Journal:  Parasitol Res       Date:  2009-07-02       Impact factor: 2.289

5.  Suppressive effect on MDC and IP-10 expression in monocytes by endocrine disruptor chemicals.

Authors:  Ching-Hui Yeh; Hsaing-Chi Wu; Thai-Hung Kuo; Chang-Hung Kuo; San-Nan Yang; Wei-Li Wang; Huan-Nan Chen; Wan-Ju Wei; Chih-Hsing Hung
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

6.  Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti.

Authors:  Kathrin Arndts; Susanne Deininger; Sabine Specht; Ute Klarmann; Sabine Mand; Tomabu Adjobimey; Alexander Y Debrah; Linda Batsa; Alexander Kwarteng; Christian Epp; Mark Taylor; Ohene Adjei; Laura E Layland; Achim Hoerauf
Journal:  PLoS Negl Trop Dis       Date:  2012-04-03

7.  CD3/TCRE Expression and Immunoregulatory Milieu Induced in a Secondary Intermediate Host by Different Phases of Hydatid Cyst.

Authors:  Alya Mashaal; Al-Shaimaa Mohsen Sadek
Journal:  Acta Parasitol       Date:  2021-06-10       Impact factor: 1.440

8.  Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients.

Authors:  Christian J Lechner; Beate Grüner; Xiangsheng Huang; Wolfgang H Hoffmann; Peter Kern; Peter T Soboslay
Journal:  Clin Dev Immunol       Date:  2012-08-30

9.  Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age.

Authors:  Francisca Mutapi; Georgina Winborn; Nicholas Midzi; Matthew Taylor; Takafira Mduluza; Rick M Maizels
Journal:  BMC Infect Dis       Date:  2007-11-28       Impact factor: 3.090

10.  Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

Authors:  Ghalia Boubaker; Andrew Hemphill; Cristina Olivia Huber; Markus Spiliotis; Hamouda Babba; Bruno Gottstein
Journal:  PLoS Negl Trop Dis       Date:  2015-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.